Recently U of L researchers, alongside scientists at Applied Pharmaceutical Innovation received a one year $210,000 grant from MITACS. The University is thrilled to be participating in work that could help the global community.
"We have some of the brightest minds in the world here in Lethbridge. To be able to address a global pandemic and issue is fantastic for our researchers to be able to apply the knowledge and skills and innovation that they have to be able to impact something on a global level," says Brandie Lea, Grants Facilitator (Partnerships) at the U of L.
"We've got a lot of expertise here in Alberta at the University of Lethbridge, University of Calgary, University of Alberta, that when combined and really thrown at this problem is very likely going to lead to potential treatments or therapies," adds Andrew MacIsaac, CEO at Applied Pharmaceutical Innovation (API).
Despite international efforts, no effective treatments or vaccines have been created yet to combat the virus.